Chronic cannabis consumption and physical exercise performance in healthy adults: a systematic review.

Athletics Cannabidiol Cannabinoids Cannabis Exercise Marijuana Physical activity Sport

Journal

Journal of cannabis research
ISSN: 2522-5782
Titre abrégé: J Cannabis Res
Pays: England
ID NLM: 101752723

Informations de publication

Date de publication:
07 Oct 2020
Historique:
received: 27 05 2020
accepted: 04 09 2020
entrez: 2 2 2021
pubmed: 3 2 2021
medline: 3 2 2021
Statut: epublish

Résumé

The effects of chronic cannabis consumption on physiological parameters of athletic performance are investigated to determine whether chronic cannabis consumption negatively affects athletic performance; improves performance, potentially via enhanced recovery; or has no effect at all. A systematic review of the literature (cross-sectional, longitudinal, and intervention studies) concerning the effects of cannabis consumption on sports performance outcomes, e.g. VO2Max (maximal oxygen uptake), PWC (physical work capacity) up to January 2020 was conducted using the PubMed, CINAHL, Medline, PsycArticles, PsycInfo, SPORTDiscus, Psychology and Behavioural Sciences Collection, and Health Source: Nursing/Academic Edition databases. After screening and additional forward searching, four articles were found to fit the inclusion criteria. Resting heart rate was the only physiological measure that significantly differed between groups, and only in one of the four studies included herein. The strongest predictors of athletic performance (VO2Max and PWC) were not found to be significantly different between groups in any of the included studies. Chronic cannabis consumption had no significant effect on athletic performance. The included studies did not assess other elements, such as recovery or endurance. No evidence exists for ergogenic or ergolytic effects from chronic cannabis consumption. In some sports, advantages may plausibly be conveyed by psychotropic enhancement or pain reduction. Further research (particularly longitudinal or interventional studies) is required to determine whether cannabis, or constituents thereof, may provide indirect supplemental benefits to athletes.

Identifiants

pubmed: 33526096
doi: 10.1186/s42238-020-00037-x
pii: 10.1186/s42238-020-00037-x
pmc: PMC7819470
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

34

Références

Clin Pharmacol Ther. 1975 Sep;18(3):287-97
pubmed: 1164818
J Int Neuropsychol Soc. 2019 Feb;25(2):134-145
pubmed: 30474579
Am Rev Respir Dis. 1975 Sep;112(3):377-86
pubmed: 1099949
PLoS One. 2019 Jun 28;14(6):e0218998
pubmed: 31251769
Sports Med Open. 2020 Jul 6;6(1):27
pubmed: 32632671
BMJ Open. 2012 Feb 24;2:e000494
pubmed: 22368296
Front Public Health. 2019 Apr 30;7:99
pubmed: 31114776
J Anal Toxicol. 2011 Nov;35(9):624-37
pubmed: 22080902
Br J Pharmacol. 2011 Aug;163(7):1344-64
pubmed: 21749363
Sports Health. 2020 Mar/Apr;12(2):189-199
pubmed: 32023171
J Thorac Dis. 2017 Jul;9(7):2079-2092
pubmed: 28840009
Med Sci Sports. 1975 Winter;7(4):309-11
pubmed: 1235156
Clin J Sport Med. 2018 Jul;28(4):350-357
pubmed: 28767469
Respir Care. 2014 Jan;59(1):90-6
pubmed: 23777656
Eur J Appl Physiol Occup Physiol. 1980;43(2):127-34
pubmed: 7389712
Clin Pharmacol Ther. 1968 Nov-Dec;9(6):783-91
pubmed: 5721981
Int J Drug Policy. 2018 Aug;58:55-63
pubmed: 29807247
J Physiol. 2014 Jan 15;592(2):377-90
pubmed: 24190933
Sports Med. 2015 Oct;45(10):1357-63
pubmed: 26178329
Med Sci Sports Exerc. 2000 Jan;32(1):70-84
pubmed: 10647532
J Strength Cond Res. 2019 Jun;33(6):1658-1668
pubmed: 29023325
J Sci Med Sport. 2017 Sep;20(9):825-829
pubmed: 28392338
Int J Cardiol. 2015 Feb 1;180:171-7
pubmed: 25460373
Med Sci Sports Exerc. 1986 Dec;18(6):685-9
pubmed: 3097453
Appl Physiol Nutr Metab. 2020 Mar;45(3):258-263
pubmed: 31319037
Obesity (Silver Spring). 2015 Feb;23(2):290-5
pubmed: 25557382
Sports Med. 2011 Nov 1;41(11):949-66
pubmed: 21985215
Cannabis Cannabinoid Res. 2018 Dec 21;3(1):259-271
pubmed: 30671538
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Clin Pharmacol Ther. 1979 Dec;26(6):777-81
pubmed: 498720

Auteurs

Andrew Kramer (A)

NICM Health Research Institute, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2751, Australia. 19178572@student.westernsydney.edu.au.
School of Psychology, Western Sydney University, Penrith, Australia. 19178572@student.westernsydney.edu.au.

Justin Sinclair (J)

NICM Health Research Institute, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2751, Australia.

Lara Sharpe (L)

NICM Health Research Institute, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2751, Australia.

Jerome Sarris (J)

NICM Health Research Institute, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2751, Australia.
Department of Psychiatry, The Melbourne Clinic, Professorial Unit, The University of Melbourne, Melbourne, Australia.

Classifications MeSH